NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project

CompletedN/A

Sponsor: CND Life Sciences

Conditions: Long COVID-19, Acute COVID-19, Postural Orthostatic Tachycardia Syndrome (POTS), Diabetic Neuropathy

Countries: United States

This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria, just one of the following:

* Long COVID-19 defined by NIH PASC criteria OR
* Acute COVID-19 who tested positive for COVID-19 without persistent symptoms OR
* Postural orthostatic tachycardia syndrome (POTS) OR
* Diabetic neuropathy

Exclusion Criteria:

* Clinical evidence of severe peripheral vascular disease
* History of ulceration, poor wound healing or vascular claudication
* History of allergic reaction to local anesthesia (for biopsy collection)
* Use of oral anticoagulants (aspirin or Plavix alone is allowed)
* History of a bleeding disorder

Locations (1)

Scottsdale, Arizona, United States